Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 44Breast Neoplasms 42Lung Neoplasms 27Carcinoma, Non-Small-Cell Lung 21Colorectal Neoplasms 19Uterine Cervical Neoplasms 13Prostatic Neoplasms 13Ovarian Neoplasms 11Head and Neck Neoplasms 11Carcinoma, Hepatocellular 11Pancreatic Neoplasms 10Melanoma 10Brain Neoplasms 9Sarcoma 7Neoplastic Cells, Circulating 7Myelodysplastic Syndromes 7Glioma 7Esophageal Neoplasms 7Endometrial Neoplasms 7Multiple Myeloma 6Gastrointestinal Neoplasms 6Disease 6Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Colonic Neoplasms 5Uveal Melanoma 4Skin Neoplasms 4Neoplasm, Residual 4

Interventions

Blood Specimen Collection 1ARQ531 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vascular Diseases × Blood Specimen Collection × 1 year × Clear all
NCT06020651 2026-04-08

VICKI

Institut Mutualiste Montsouris

Phase NA Completed
39 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Neoplasms, Vascular Diseases, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡